e.g. Tata motors, Reliance MF, 500570

Shukra Pharmaceuticals Ltd. - Research Center

524632 SHUKRAPHAR Group (XT) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 74.57 58.83 20.49 11.20 11.85
Expenses
Material consumed 44.49 45.32 10.35 2.77 3.00
Manufacturing expenses - - - 1.78 1.64
Personnel expenses 5.65 4.89 4.90 4.07 4.40
Selling expenses 0.04 0.01 - - -
Adminstrative expenses 5.00 3.25 2.35 1.13 1.27
Expenses capitalised - - - - -
Cost of sales 55.17 53.47 17.60 9.75 10.31
Operating profit 19.40 5.36 2.89 1.44 1.54
Other recurring income 2.82 1.20 0.08 0.36 0.01
Adjusted PBDIT 22.22 6.56 2.97 1.80 1.55
Financial expenses 0.29 0.28 0.29 0.03 -
Depreciation 2.05 1.84 1.66 1.47 1.48
Other write offs - - - - -
Adjusted PBT 19.88 4.44 1.02 0.29 0.07
Tax charges 1.35 0.04 0.27 0.06 0.14
Adjusted PAT 18.54 4.41 0.75 0.23 -0.07
Non recurring items 0.01 -0.01 - -0.20 0.10
Other non cash adjustments - - - - -
Reported net profit 18.55 4.40 0.75 0.03 0.04
Earnigs before appropriation 37.66 19.18 14.78 9.87 9.69
Equity dividend 0.07 0.08 - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 37.59 19.10 14.78 9.87 9.69
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback